| Description | Bulevirtide (Myrcludex B) acetate is a virion entry inhibitor which blocks the virion's hepatocyte pathway of entry, the hepatic sodium/taurocholate cotransporting polypeptide (NTCP) receptor. Bulevirtide (Myrcludex B) acetate can be used in HBV and HDV infection studies. |
| molecular weight | 5458.91 |
| Molecular formula | C236H333N65O73 |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | H2O: Insoluble DMSO: 100 mg/mL (18.32 mM) |
| References | 1. Yardeni D, Koh C. Bulevirtide for HBV and HDV infections. Drugs Today (Barc). 2021 Jul;57(7):433-448. |